Application 079022

Type: ANDA
Sponsor: TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	CAPSULE;ORAL	10MG	No	No
002	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	CAPSULE;ORAL	18MG	No	No
003	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	CAPSULE;ORAL	25MG	No	No
004	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	CAPSULE;ORAL	40MG	No	No
005	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	CAPSULE;ORAL	60MG	No	No
006	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	CAPSULE;ORAL	80MG	No	No
007	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	CAPSULE;ORAL	100MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 7 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A079022-001	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2017-05-30
A079022-002	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	EQ 18MG BASE	CAPSULE / ORAL	AB	2017-05-30
A079022-003	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	AB	2017-05-30
A079022-004	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE / ORAL	AB	2017-05-30
A079022-005	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE / ORAL	AB	2017-05-30
A079022-006	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	EQ 80MG BASE	CAPSULE / ORAL	AB	2017-05-30
A079022-007	ATOMOXETINE HYDROCHLORIDE	ATOMOXETINE HYDROCHLORIDE	EQ 100MG BASE	CAPSULE / ORAL	AB	2017-05-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 7 matching rows.

Application-product, TE code table
Application-product	TE code
A079022-001	AB
A079022-002	AB
A079022-003	AB
A079022-004	AB
A079022-005	AB
A079022-006	AB
A079022-007	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 8 · 294 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A079022-001	ATOMOXETINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2017-05-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-002	ATOMOXETINE HYDROCHLORIDE	EQ 18MG BASE	CAPSULE / ORAL	AB	2017-05-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-003	ATOMOXETINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	AB	2017-05-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-004	ATOMOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE / ORAL	AB	2017-05-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-005	ATOMOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE / ORAL	AB	2017-05-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-006	ATOMOXETINE HYDROCHLORIDE	EQ 80MG BASE	CAPSULE / ORAL	AB	2017-05-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-007	ATOMOXETINE HYDROCHLORIDE	EQ 100MG BASE	CAPSULE / ORAL	AB	2017-05-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A079022-001	ATOMOXETINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2017-05-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-002	ATOMOXETINE HYDROCHLORIDE	EQ 18MG BASE	CAPSULE / ORAL	AB	2017-05-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-003	ATOMOXETINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	AB	2017-05-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-004	ATOMOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE / ORAL	AB	2017-05-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-005	ATOMOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE / ORAL	AB	2017-05-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-006	ATOMOXETINE HYDROCHLORIDE	EQ 80MG BASE	CAPSULE / ORAL	AB	2017-05-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-007	ATOMOXETINE HYDROCHLORIDE	EQ 100MG BASE	CAPSULE / ORAL	AB	2017-05-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-001	ATOMOXETINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2017-05-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-002	ATOMOXETINE HYDROCHLORIDE	EQ 18MG BASE	CAPSULE / ORAL	AB	2017-05-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-003	ATOMOXETINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	AB	2017-05-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-004	ATOMOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE / ORAL	AB	2017-05-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-005	ATOMOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE / ORAL	AB	2017-05-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-006	ATOMOXETINE HYDROCHLORIDE	EQ 80MG BASE	CAPSULE / ORAL	AB	2017-05-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-007	ATOMOXETINE HYDROCHLORIDE	EQ 100MG BASE	CAPSULE / ORAL	AB	2017-05-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A079022-001	ATOMOXETINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2017-05-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-002	ATOMOXETINE HYDROCHLORIDE	EQ 18MG BASE	CAPSULE / ORAL	AB	2017-05-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-003	ATOMOXETINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	AB	2017-05-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-004	ATOMOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE / ORAL	AB	2017-05-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-005	ATOMOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE / ORAL	AB	2017-05-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-006	ATOMOXETINE HYDROCHLORIDE	EQ 80MG BASE	CAPSULE / ORAL	AB	2017-05-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-007	ATOMOXETINE HYDROCHLORIDE	EQ 100MG BASE	CAPSULE / ORAL	AB	2017-05-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-001	ATOMOXETINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2017-05-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-002	ATOMOXETINE HYDROCHLORIDE	EQ 18MG BASE	CAPSULE / ORAL	AB	2017-05-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-003	ATOMOXETINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	AB	2017-05-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-004	ATOMOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE / ORAL	AB	2017-05-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-005	ATOMOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE / ORAL	AB	2017-05-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-006	ATOMOXETINE HYDROCHLORIDE	EQ 80MG BASE	CAPSULE / ORAL	AB	2017-05-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-007	ATOMOXETINE HYDROCHLORIDE	EQ 100MG BASE	CAPSULE / ORAL	AB	2017-05-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-001	ATOMOXETINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2017-05-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-002	ATOMOXETINE HYDROCHLORIDE	EQ 18MG BASE	CAPSULE / ORAL	AB	2017-05-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-003	ATOMOXETINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	AB	2017-05-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-004	ATOMOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE / ORAL	AB	2017-05-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-005	ATOMOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE / ORAL	AB	2017-05-30	`b8a1b40f171c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 8 · 294 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A079022-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-006	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079022-007	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A079022-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-006	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079022-007	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-006	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079022-007	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A079022-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-006	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079022-007	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-006	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079022-007	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-004	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079022-005	AB	1	`b8a1b40f171c…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atomoxetine	ATOMOXETINE	AvKARE	dc7ba02c-bdbb-5136-e053-2995a90ac545	2026-01-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079022 application number: ANDA079022 ndc (product): 42291-064 ndc (product): 42291-070 ndc (product): 42291-067 ndc (product): 42291-066 ndc (product): 42291-065 ndc (product): 42291-068 ndc (product): 42291-069
Atomoxetine	ATOMOXETINE	A-S Medication Solutions	ddec2943-483d-403a-838c-cbdb6eefe0a1	2025-12-16	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079022 application number: ANDA079022
Atomoxetine	ATOMOXETINE	A-S Medication Solutions	96855061-440f-4c99-a152-cf8da8e2b1b3	2023-10-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079022 application number: ANDA079022 ndc (product): 50090-6254
Atomoxetine	ATOMOXETINE	A-S Medication Solutions	aa109260-6d4c-429c-9957-19cbe0e34485	2023-10-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079022 application number: ANDA079022 ndc (product): 50090-6289
Atomoxetine	ATOMOXETINE	A-S Medication Solutions	402711d7-bd44-4f2a-ad2b-4756cdc68645	2023-06-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079022 application number: ANDA079022
Atomoxetine	ATOMOXETINE	Teva Pharmaceuticals USA, Inc.	4953df7b-ccdb-452c-8699-5fd7259609b4	2023-04-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079022 application number: ANDA079022 ndc (product): 0093-3548 ndc (product): 0093-3543 ndc (product): 0093-3544 ndc (product): 0093-3545 ndc (product): 0093-3546 ndc (product): 0093-3547 ndc (product): 0093-3542

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 72 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA,	ANDA	Current
0093-3542	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA,	ANDA	Current
0093-3543	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA,	ANDA	Current
0093-3544	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA,	ANDA	Current
0093-3545	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA,	ANDA	Current
0093-3546	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA,	ANDA	Current
0093-3547	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA,	ANDA	Current
0093-3548	Atomoxetine	Atomoxetine	Teva Pharmaceuticals USA, Inc.	ANDA	Current
42291-064	Atomoxetine	Atomoxetine	AvKARE	ANDA	Current
42291-065	Atomoxetine	Atomoxetine	AvKARE	ANDA	Current
42291-066	Atomoxetine	Atomoxetine	AvKARE	ANDA	Current
42291-067	Atomoxetine	Atomoxetine	AvKARE	ANDA	Current
42291-068	Atomoxetine	Atomoxetine	AvKARE	ANDA	Current
42291-069	Atomoxetine	Atomoxetine	AvKARE	ANDA	Current
42291-070	Atomoxetine	Atomoxetine	AvKARE	ANDA	Current
50090-6254	Atomoxetine	Atomoxetine	A-S Medication Solutions	ANDA	Current
50090-6289	Atomoxetine	Atomoxetine	A-S Medication Solutions	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
48627	ORIG	2017-06-02